An evaluation of the effects of an angiotensin receptor blocker on health-related quality of life in patients with high-normal blood pressure (prehypertension) in the trial of preventing hypertension (TROPHY)

Journal of Clinical Hypertension

Volumn 10, Issue 6, 2008, Pages 436-442

  Williams, Setareh A ^a   Michelson, Eric L ^a   Cain, Valerie A ^a   Yang, Min ^b   Nesbitt, Shawna D ^c   Egan, Brent M ^d   Julius, Stevo ^e  

^a ASTRAZENECA   (United Kingdom)

^b QualityMetric Incorporated   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANDESARTAN; PLACEBO; ANGIOTENSIN RECEPTOR ANTAGONIST; BENZIMIDAZOLE DERIVATIVE; TETRAZOLE DERIVATIVE;

ADULT; ARTICLE; CLINICAL EVALUATION; COMORBIDITY; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; HEALTH STATUS; HUMAN; HYPERTENSION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MENTAL PERFORMANCE; PHYSICAL PERFORMANCE; PREHYPERTENSION; PRIORITY JOURNAL; QUALITY OF LIFE; SELF REPORT; SHORT FORM 36; SOCIAL INTERACTION; TREATMENT OUTCOME; AGED; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; INCIDENCE; MIDDLE AGED; MULTICENTER STUDY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; UNITED STATES;

ADULT; AGED; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; BENZIMIDAZOLES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; PLACEBOS; QUALITY OF LIFE; QUESTIONNAIRES; TETRAZOLES; TREATMENT OUTCOME; UNITED STATES;

EID: 55249104405     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2008.07837.x     Document Type: Article

References (22)

1. Testa MA, Anderson RB, Nackley JF, et al. Quality of life and antihypertensive therapy in men-A comparison of captopril and enalapril. The Quality-of-Life Hypertension Study Group. N Engl J Med. 1993;328(13):907-913.
2. Erickson SR, Williams BC, Gruppen LD, et al. Perceived symptoms and health-related quality of life reported by uncomplicated hypertensive patients compared to normal controls. J Hum Hypertens. 2001;15(8):539-548.
3. Materson BJ, Reda DJ, Cushman WC, et al. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. N Engl J Med. 1993;328(13):914-921.
4. Neaton JD, Grimm RH Jr, Prineas RJ, et al. Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group. JAMA. 1993;270(6):713-724.
5. Coyne KS, Davis D, Frech F, et al. Health-related quality of life in patients treated for hypertension: A review of the literature from 1990 to 2000. Clin Ther. 2002;24(1):142-169.
6. Julius S, Nesbitt SD, Egan BM, et al; Trial of Preventing Hypertension (TROPHY) Study Investigators. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med. 2006;354(16):1685-1697.
7. Lawrence WF. Health status and hypertension: A population-based study. J Clin Epidemiol. 1996;49(11):1239-1245.
8. Erickson SR, Williams BC, Gruppen LD. Relationship between symptoms and health-related quality of life in patients treated for hypertension. Pharmacotherapy. 2004;24(3):344-350.
9. Côte I, Grégoire JP, Moisan J. Health-related quality-of-life measurement in hypertension: A review of randomized controlled drug trials. Pharmacoeconomics. 2000;18(5):435-450.
10. Ware JE, Kosinski M, Keller SD. SF-36 Physical and Mental Health Summary Scales: A User's Manual. Boston, MA: The Health Institute; 1994.
11. Ware JE Jr, Kosinski M. SF-36 Physical and Mental Health Summary Scales: A Manual for Users of Version 1. 2nd ed. Lincoln, RI: QualityMetric Incorporated; 2001.
12. Tarlov AR, Ware JE Jr, Greenfield S, et al. The Medical Outcomes Study. An application of methods for monitoring the results of medical care. JAMA. 1989;262(7):925-930.
13. Blissmer B, Reibe D, Dye G, et al. Health-related quality of life following a clinical weight loss intervention among overweight and obese adults: Intervention and 24 month follow-up effect. Health Qual Life Outcomes. 2006;4:43.
14. Sievert LL, Goode-Null SK. Musculoskeletal pain among women of menopausal age in Puebla, Mexico. J Cross Cult Gerontol. 2005;20(2):127-140.
15. Dahlöf B, Degl' Innocenti A, Elmfeldt D, et al. Felodipine-metoprolol combination tablet: Maintained health-related quality of life in the presence of substantial blood pressure reduction. Am J Hypertens. 2005;18(10):1313-1319.
16. Fogari R, Zoppi A. Effect of antihypertensive agents on quality of life in the elderly. Drugs Aging. 2004;21(6):377-393.
17. Zyczynski TM, Leidy NK, Kong BW, et al; Association of Black Cardiologists (ABC) Candesartan Study Group. Effects of candesartan cilexetil on health-related quality of life in black patients with systemic hypertension in the ABC Trial. Heart Dis. 2000;2(6):400-406.
18. Degl'Innocenti A, Elmfeldt D, Hofman A, et al. Health-related quality of life in elderly treated hypertensive patients: Data from the Study on Cognition and Prognosis in the Elderly (SCOPE). J Hum Hypertens. 2004;18(4):239-245.
19. Coons SJ, Rao S, Keininger DL, et al. A comparative review of generic quality of life instruments. Pharmacoeconomics. 2000;17(1):13-35.
20. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med. 1993;118(8):622-629.
21. Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Med Care. 1989;27(suppl 3):S217-S232.
22. Stein JD, Brown GC, Brown MM, et al. The quality of life of patients with hypertension. J Clin Hypertens (Greenwich). 2002;4(3):181-188.